Pharmacology, Toxicology and Pharmaceutical Science
Acetic Acid Derivative
5%
Acute Heart Failure
5%
Acute Heart Infarction
8%
All Cause Mortality
6%
Anemia
30%
Apixaban
8%
Atrial Fibrillation
10%
Biological Marker
8%
Bleeding
6%
Blood Clotting Factor 10a
5%
Brain Natriuretic Peptide
12%
Calcium Calmodulin Dependent Protein Kinase II
8%
Cardiovascular Disease
9%
Clinical Trial
5%
Erythropoietin
29%
Heart Arrhythmia
7%
Heart Disease
6%
Heart Failure
100%
Heart Failure with Preserved Ejection Fraction
9%
Heart Failure with Reduced Ejection Fraction
10%
Heart Infarction
20%
Heart Muscle Ischemia
9%
Heart Ventricle Remodeling
8%
Ischemia
5%
Ketone Bodies
15%
Neovascularization (Pathology)
6%
Recombinant Erythropoietin
9%
Sodium Glucose Cotransporter 2
5%
Thromboembolism
5%
Vasculotropin
5%
Medicine and Dentistry
Adipose Tissue
11%
Anemia
13%
Apixaban
5%
Atrial Fibrillation
6%
Biological Marker
7%
Brain Natriuretic Peptide
9%
Cardiac Magnetic Resonance Imaging
8%
Cardiac Muscle Cell
10%
Cardiovascular Disease
6%
Cardiovascular System
11%
Congestive Heart Failure
8%
Diabetes Mellitus
6%
Disease
7%
Ejection Fraction
22%
Empagliflozin
6%
Endothelial Progenitor Cell
6%
Erythropoietin
14%
Hazard Ratio
6%
Heart Failure
75%
Heart Failure with Preserved Ejection Fraction
9%
Heart Failure with Reduced Ejection Fraction
10%
Heart Function
20%
Heart Left Ventricle Ejection Fraction
10%
Heart Left Ventricle Failure
6%
Heart Muscle Ischemia
6%
Heart Ventricle Remodeling
6%
Ketone Bodies
17%
Myocardial Infarction
16%
Pathophysiology
5%
Sodium Glucose Cotransporter 2
8%
Vasculotropin
5%
Keyphrases
Acute Heart Failure
5%
All-cause Mortality
7%
Anemia
11%
Cardiac Function
11%
Epicardial Adipose Tissue
11%
Epicardial Adipose Tissue Volume
5%
Erythropoietin
8%
Heart Failure
34%
Heart Failure Patients
14%
Heart Failure with Preserved Ejection Fraction (HFpEF)
18%
Ketone Bodies
10%
Left Ventricular Ejection Fraction
6%
Myocardial Infarction
6%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
7%
Obesity
5%
Patients with Heart Failure
10%
Population-based Cohort
5%
Preserved Ejection Fraction
9%
Prognostic Value
6%